BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15982307)

  • 1. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
    Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
    J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
    Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
    J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
    Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
    Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
    Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
    Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
    Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
    Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xeroderma pigmentosum-Cockayne syndrome complex.
    Natale V; Raquer H
    Orphanet J Rare Dis; 2017 Apr; 12(1):65. PubMed ID: 28376890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells.
    Vélez-Cruz R; Zadorin AS; Coin F; Egly JM
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):E212-20. PubMed ID: 23267107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria.
    Andressoo JO; Mitchell JR; de Wit J; Hoogstraten D; Volker M; Toussaint W; Speksnijder E; Beems RB; van Steeg H; Jans J; de Zeeuw CI; Jaspers NG; Raams A; Lehmann AR; Vermeulen W; Hoeijmakers JH; van der Horst GT
    Cancer Cell; 2006 Aug; 10(2):121-32. PubMed ID: 16904611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
    Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
    Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
    Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
    Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.
    Reid-Bayliss KS; Arron ST; Loeb LA; Bezrookove V; Cleaver JE
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10151-6. PubMed ID: 27543334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity.
    Botta E; Nardo T; Broughton BC; Marinoni S; Lehmann AR; Stefanini M
    Am J Hum Genet; 1998 Oct; 63(4):1036-48. PubMed ID: 9758621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
    Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome.
    Theron T; Fousteri MI; Volker M; Harries LW; Botta E; Stefanini M; Fujimoto M; Andressoo JO; Mitchell J; Jaspers NG; McDaniel LD; Mullenders LH; Lehmann AR
    Mol Cell Biol; 2005 Sep; 25(18):8368-78. PubMed ID: 16135823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
    Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
    Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of compound heterozygosity at the Xpd locus on cancer and ageing in mouse models.
    van de Ven M; Andressoo JO; van der Horst GT; Hoeijmakers JH; Mitchell JR
    DNA Repair (Amst); 2012 Nov; 11(11):874-83. PubMed ID: 23046824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.
    Coin F; Bergmann E; Tremeau-Bravard A; Egly JM
    EMBO J; 1999 Mar; 18(5):1357-66. PubMed ID: 10064601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.